ICPT Stock Tumbles On New Obstacle For Its NASH Drug The post ICPT Stock Tumbles On New Obstacle For Its NASH Drug appeared on BitcoinEthereumNews.com. Intercept Pharmaceuticals (ICPT) said Friday its experimental liver disease treatment will face a Food and Drug Administration panel in May, leading ICPT stock to tumble. X The FDA’s Gastrointestinal Drugs… Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Filed under: News - @ March 11, 2023 8:58 pm